Health In Tech, Inc. (HIT)
| Market Cap | 58.88M +38.0% |
| Revenue (ttm) | 34.08M +52.3% |
| Net Income | -808,031 |
| EPS | -0.02 |
| Shares Out | 65.53M |
| PE Ratio | n/a |
| Forward PE | 775.74 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 559,517 |
| Open | 0.9400 |
| Previous Close | 0.9225 |
| Day's Range | 0.8501 - 0.9400 |
| 52-Week Range | 0.5551 - 4.0200 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 4.03 (+348.53%) |
| Earnings Date | May 13, 2026 |
About HIT
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to qu... [Read more]
Financial Performance
In 2025, Health In Tech's revenue was $33.33 million, an increase of 70.99% compared to the previous year's $19.49 million. Earnings were $1.28 million, an increase of 90.74%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for HIT stock is "Buy." The 12-month stock price target is $4.03, which is an increase of 348.53% from the latest price.
News
Health In Tech Registration statement: Registration filing
Health In Tech filed a registration statement on May 22, 2026, providing details about a securities offering with the SEC.
Health In Tech Q1 Earnings Call Highlights
Health In Tech NASDAQ: HIT reported first-quarter 2026 revenue growth and a wider loss as management said the company is intentionally increasing investment in sales distribution, carrier relationship...
Health In Tech Earnings Call Transcript: Q1 2026
Q1 2026 revenue grew 9% to $8.8M, with a net loss of $1.6M as investments in sales, tech, and distribution accelerated. Full-year revenue guidance of $45–$50M was reiterated, and new platform features and products are driving positive broker feedback and future growth.
Health In Tech Slides: Q1 2026
Health In Tech has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 13, 2026.
Health In Tech Earnings release: Q1 2026
Health In Tech released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
Health In Tech Quarterly report: Q1 2026
Health In Tech has published its Q1 2026 quarterly earnings report on May 13, 2026.
Health In Tech reports Q1 EPS (3c), consensus (2c)
Reports Q1 revenue $8.8M, consensus $7.46M. Tim Johnson, Chief Executive Officer of Health In Tech (HIT), commented, “In the first quarter of 2026, we continued to execute on strategic priorities…
Health In Tech backs FY26 revenue view $45M-$50M, consensus $46.36M
Health In Tech (HIT) reiterated guidance for 2026 annual revenue ranging between $45M-$50M, representing year-over-year growth of approximately 35% to 50%. As of March 31, 2026, the company’s contract...
Health In Tech Reports First Quarter 2026 Financial Results
Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 Million STUART, Fla., May 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), a...
Health In Tech to Announce First Quarter 2026 Financial Results on May 13, 2026
STUART, Fla., April 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the first quarter ...
Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)
FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HIT Phase 2 data showed a greater than 25% absolute reduction in thrombotic events when CAD-1005 was added to stand...
Health In Tech files to sell 5.6M shares of Class A common stock for holders
17:08 EDT Health In Tech (HIT) files to sell 5.6M shares of Class A common stock for holders
Health In Tech Registration statement: Registration filing
Health In Tech filed a registration statement on April 24, 2026, providing details about a securities offering with the SEC.
Health In Tech to Present at the Market Movers Investor Summit
STUART, Fla., April 21, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an AI-enabled InsurTech platform company, today announced that it will be participating in the Market M...
Craig-Hallum bullish on Health In Tech, initiates with a Buy
AS previously reported, Craig-Hallum analyst George Sutton initiated coverage of Health In Tech (HIT) with a Buy rating and $4 price target The firm sees this as a “big idea”…
Health In Tech initiated with a Buy at Craig-Hallum
Craig-Hallum initiated coverage of Health In Tech (HIT) with a Buy rating and $4 price target
Health In Tech Announces Closing of $7.0 Million Private Placement
STUART, Fla., March 27, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced the closing of its previo...
Health In Tech price target lowered to $4 from $4.50 at Maxim
Maxim lowered the firm’s price target on Health In Tech (HIT) to $4 from $4.50 and keeps a Buy rating on the shares. The firm is adjusting its model to…
Health In Tech announces $7M private placement
Health In Tech (HIT) announced that it has entered into a securities purchase agreement for a private investment in public equity financing that is expected to result in gross proceeds…
Health In Tech Announces $7.0 Million Private Placement
STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced that it has entered into ...
Health In Tech Earnings Call Transcript: Q4 2025
Revenue grew 71% to $33.3M in 2025, driven by distribution and platform expansion, with adjusted EBITDA up 81%. 2026 guidance targets $45M–$50M revenue, supported by new large employer offerings, AI investments, and a three-year rate stabilization program.
Health In Tech Annual report: Q4 2025
Health In Tech has published its Q4 2025 annual report on March 25, 2026.
Health In Tech Earnings release: Q4 2025
Health In Tech released its Q4 2025 earnings on March 25, 2026, summarizing the period's financial results.
Health In Tech Slides: Q4 2025
Health In Tech has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 25, 2026.
Health In Tech reports Q4 EPS (1c) vs. 0c last year
Reports Q4 revenue $7.51M vs. $4.9M last year. Tim Johnson, CEO of Health In Tech (HIT), commented, “2025 was a defining year of disciplined execution and measurable platform scale for…